Healthy Extracts AI Stock Analysis
Want to see HYEX full AI Analyst Report?
Healthy Extracts (HYEX) AI Stock Analysis
Healthy Extracts
(Other OTC:HYEX)
The score reflects a high-risk turnaround situation. Positive cash flow and bullish technical momentum are the primary strengths, but they are significantly counterbalanced by persistent net losses, a negative P/E, and recent corporate governance uncertainty following a board resignation.
Healthy Extracts (HYEX) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $19.92M
- Dividend Yield
- ―
- Average Volume (3M)
- 720
- Price to Earnings (P/E)
- -9.1
- Beta (1Y)
- 2.51
- Revenue Growth
- 66.93%
- EPS Growth
- 54.88%
- Country
- US
- Employees
- 22
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Drug Manufacturers - Specialty & Generic
Healthy Extracts Business Overview & Revenue Model
Company Description
Healthy Extracts Inc., through its various divisions, specializes in the global and domestic research, development, and sale of natural botanical products. Its portfolio encompasses dietary supplements crafted for cardiovascular wellness, alongside K...
Healthy Extracts Financial Statement Overview
Summary
Mixed financials: strong cash flow (Score 70) and improved balance sheet (Score 60) are offset by deeply unprofitable operations (Income Score 35). The company is a turnaround story with positive cash generation but no clear path to net profitability.
Income Statement
35NegativeBalance Sheet
60NeutralCash Flow
70Positive| Breakdown | TTM | Dec 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.99M | 4.51M | 3.11M | 2.49M | 2.25M | 1.47M |
| Gross Profit | 3.74M | 2.42M | 1.91M | 1.62M | 1.37M | 695.08K |
| EBITDA | -1.27M | -791.66K | -183.15K | -2.24M | -910.71K | -1.88M |
| Net Income | -2.20M | -881.12K | -840.67K | -2.47M | -983.12K | -1.99M |
Balance Sheet | ||||||
| Total Assets | 32.14M | 27.82M | 2.38M | 2.64M | 2.78M | 3.03M |
| Cash, Cash Equivalents and Short-Term Investments | 143.27K | 146.94K | 112.02K | 19.44K | 65.65K | 222.10K |
| Total Debt | 9.13M | 2.64M | 941.90K | 1.13M | 593.52K | 342.62K |
| Total Liabilities | 10.93M | 3.80M | 1.97M | 1.68M | 902.79K | 558.84K |
| Stockholders Equity | 21.20M | 24.03M | 410.38K | 954.59K | 1.88M | 2.47M |
Cash Flow | ||||||
| Free Cash Flow | 723.56K | 146.22K | 281.97K | -415.75K | -342.95K | -997.30K |
| Operating Cash Flow | 723.56K | 165.52K | 281.97K | -415.75K | -334.96K | -901.30K |
| Investing Cash Flow | 134.71K | 56.30K | 0 | 0 | -5,344 | -96.00K |
| Financing Cash Flow | -904.45K | -186.91K | -189.39K | 369.54K | 239.52K | 1.16M |
Healthy Extracts Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HYEX, the sentiment is Positive. The current price of 1.35 is above the 20-day moving average (MA) of 1.32, above the 50-day MA of 1.15, and below the 200-day MA of 1.60, indicating a neutral trend. The MACD of 0.06 indicates Positive momentum. The RSI at 68.23 is Neutral, neither overbought nor oversold. The STOCH value of -2.04 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HYEX.
Healthy Extracts Risk Analysis
Healthy Extracts disclosed 11 risk factors in its most recent earnings report. Healthy Extracts reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
2 New RisksHealthy Extracts Peers Comparison
Overall Rating
RMTI56Neutral
AYTU55Neutral
CPIX55Neutral
HYEX53Neutral
SCYX45Neutral
COSM38Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 56Neutral | $24.86M | -4.23 | -16.04% | ― | -3.96% | 7.97% | |
| 55Neutral | $28.91M | -1.49 | -69.19% | ― | -8.12% | 7.24% | |
| 55Neutral | $94.47M | 1.37 | 202.58% | 22.00% | -39.11% | -241.27% | |
| 53Neutral | $19.92M | -9.07 | -9.59% | ― | 66.93% | 54.88% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 45Neutral | $25.93M | -2.23 | -18.65% | ― | 543.96% | 72.49% | |
| 38Underperform | $14.44M | -0.22 | -118.89% | ― | 33.82% | 34.05% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HYEX | Healthy Extracts Inc | 1.35 | -0.67 | -33.12% | |
| RMTI | Rockwell Medical | 6.26 | -2.65 | -29.77% | |
| SCYX | SCYNEXIS Inc | 2.60 | -2.84 | -52.11% | |
| AYTU | Aytu BioScience | 2.66 | 0.65 | 32.34% | |
| CPIX | Cumberland Pharmaceuticals Inc. | 6.30 | 4.76 | 309.36% | |
| COSM | Cosmos Holdings | 2.87 | -10.68 | -78.82% |
Healthy Extracts Corporate Events
Healthy Extracts Enters Secured Convertible Note Financing Agreement
NeutralOn November 10, 2026, the company entered into a securities purchase agreement and issued HINTERLAND PARTNERS LLC a secured promissory note with a $555,556 principal amount, a $55,556 original issue discount, a 30-month maturity and 13% annual intere...
Healthy Extracts Announces Board Change After Director Resignation
NegativeHealthy Extracts, operating in the broader health and wellness sector, is overseen by a board of directors responsible for guiding its corporate governance and strategic direction. The company relies on its board committees to manage oversight functi...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 20, 2026
